Position in LH
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$281,400
-$85,463 QoQ
Shares Held
1,005
-26.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#714
of 1,040 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Lido Advisors, LLC holds $51,871,777 across 18 Diagnostics & Research names. LH ranks #15 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
43,094 | $21,605,606 | |
| 2 | DHR |
Danaher Corp /De/
|
77,419 | $14,746,770 | |
| 3 | A |
Agilent Technologies, Inc.
|
22,399 | $2,975,258 | |
| 4 | RDNT |
RadNet, Inc.
|
37,274 | $2,298,687 | |
| 5 | GRAL |
GRAIL, Inc.
|
33,254 | $2,270,250 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
3,884 | $2,044,692 | |
| 7 | WAT |
Waters Corp /De/
|
2,945 | $1,104,492 | |
| 8 | NTRA |
Natera, Inc.
|
3,203 | $869,453 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $281,400 | 1,005 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $366,863 | 1,375 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $566,486 | 2,258 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $632,392 | 2,203 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $725,052 | 2,762 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $2,231,975 | 9,590 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,579,849 | 11,250 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $8,863,886 | 39,663 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $373,033 | 1,833 | Shares | Sole | 2024-08-15 | |
| No filing history on record for this holder in this stock. | ||||||